ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
AstraZeneca’s drugs with potential in 2018
Shulin Yang
February 12, 2018The pharmaceutical product sales of AstraZeneca declined by 5% in 2017, to which Onglyza, Symbicort, and Crestor, etc. could be said to have made “big contributions”.
Pharma Sources Insight January 2025
